Blocknomi
TLDR Johnson & Johnson gains momentum after FDA approves Imaavy for rare blood disorder. JNJ expands cancer care reach after Europe approves Tecvayli combination treatment. New approvals strengthen Johnson &…
Related articles
-
Polish Olympic Committee president detained in Zondacrypto bribery probe
The Block Published 27.08.2026 18:23
-
AST SpaceMobile Inc. (ASTS) Stock: Surges as BlueBird 12 and 13 Deployment Sparks Momentum
Blocknomi Published 28.08.2026 09:06
-
Arbitrum (ARB) Pumps 27% Daily: The Start of a Bigger Move?
CryptoPotato Published 01.09.2026 17:44
-
Bitcoin to Solana: How 8 Crypto Networks Reach Consensus
Bitcoin.com Published 24.08.2026 04:30
-
Bullish Zone: XRP Ledger Prints 200% Increase, With 103% Surge in Volume
U.Today Published 31.08.2026 10:10
-
OpenAI Releases GPT-6 Astra: The Closest AI Model Yet to AGI
Decrypt Published 03.09.2026 19:24
-
Stock Futures Slide as Middle East Tensions and Fed Hawkishness Weigh on Markets
Blocknomi Published 31.08.2026 11:07
-
'This Seems Incorrect': Ripple CTO Emeritus Slams Kalshi CFTC Argument
U.Today Published 29.08.2026 14:00